The Mehta Family Centre for Engineering in Medicine

Indian Institute of Technology Kanpur

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

MFCEM@IITK

The next generation of healthcare innovation lies at the interface of multiple disciplines involving engineering and medicine. The Mehta Family Centre for Engineering in Medicine at IIT Kanpur strives to act as a catalyst for biomedical researchers and engineers to work together on challenging medical problems.

MFCEM Building
Foundation Day Celebration at IITK
Inauguration of the Mehta Family Centre for Engineering in Medicine
MFCEM Inaugural Research Symposium: Session1- Molecular Medicine
MFCEM Inaugural and Research Sympoisum: Quiz Bowl
MFCEM inauguration and research symposium: Session on Regenerative Medicine
MFCEM inaugural and research symposium
MFCEM Inaugural and Research Symposium: Felicitation and Concluding session
MFCEM inauguration and research symposium: session on Digital Medicine
In conversation with the first author, Aman Nikhil
Evaluating potential of tissue-engineered cryogels and chondrocyte derived exosomes in articular cartilage repair.

Nikhil Aman and Kumar Ashok.

Biotechnol Bioeng. 2021 Nov 1.

What gap does your study addresses?
Aman Nikhil: Cartilage repair still faces limitations like phenotype instability and poor integration with surrounding tissue. In our study, we utilized chondrocyte exosomes as paracrine signaling molecules which will help to maintain the phenotype of formed cartilage. Further, these exosomes were utilized in combination with chondroitin sulfate releasing cryogel which was shown to act as exosome delivery system and due to its properties of high compressibility and elasticity, it will integrate well on swelling with the defect area.

What was the most challenging part of the study?
Aman Nikhil: In this study we strived to utilize chondrocyte exosomes as a cell free therapy and designing different cryogel scaffolds to better mimic the architecture and constituents of the cartilage and subchondral bone. So, we proposed the combinatorial approach of exosome laden cryogels for cartilage regeneration. Further, to overcome the problem of delamination of bi-layered cryogel, the two layers were joined in single cross-linking reaction with gelatin as a common polymer in both layers.

How do you evaluate the translation potential of this study?
Aman Nikhil: To evaluate the translation potential, animal experimentation is required where the potential of these exosome laden cryogels can be evaluated. For cartilage, higher animal models like goat, sheep or horse are preferred because of the similarity of their stifle joint to humans. Although preliminary studies can be performed in rabbit (Gupta et al., 2017) where the biocompatibility and regeneration potential can be tested.

Where do you see the application of this study, particularly in the Indian context?
Aman Nikhil: Indian population is prone to osteoarthritis (OA) which is musculoskeletal joint disorder affecting cartilage having prevalence of 22% to 39%. Approximately, 45% of women over the age of 65 have OA related symptoms (Cui et al., 2020). In addition, trauma injuries (accidents, sports injuries) also cause damage to knee cartilage and subchondral bone. So, tissue engineering strategy mentioned in this study has application for treatment of such osteochondral defects.

Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. 2020. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine 29:100587.
Gupta A, Bhat S, Chaudhari BP, Gupta KC, Tägil M, Zheng MH, Kumar A, Lidgren L. 2017. Cell factory‐derived bioactive molecules with polymeric cryogel scaffold enhance the repair of subchondral cartilage defect in rabbits. J. Tissue Eng. Regen. Med. 11:1689–1700. https://doi.org/10.1002/term.2063.

In conversation with the first author, Srinivasarao
Simultaneous amelioration of diabetic ocular complications in lens and retinal tissues using a non-invasive drug delivery system.

Srinivasarao DA, Sreenivasa Reddy S, Bhanuprakash Reddy G, Katti DS.

Int J Pharm. 2021 Oct 25; 608:121045.

How would you describe the major breakthrough of this study?
Srinivasarao:In this study, we succeeded in delivering two therapeutic agents [an antioxidant, pyrrolidine dithiocarbamate (PDTC) and an anti-VEGF agent, triamcinolone acetonide (TA)] simultaneously to anterior (lens) and posterior (retina) ocular tissues using polymeric core-shell nanoparticles (NPs). Further, controlled release of entrapped drugs (burst followed by sustained release of PDTC, whereas, a slow and sustained release of TA) was achieved using the fabricated delivery system. As a consequence, the developed drug delivery/therapeutic strategy minimized diabetes associated cataract and retinopathy in diabetic retinopathy rats.

What was the most challenging part of the study?
Srinivasarao:There are multiple experiments that were challenging, which include fabrication of NPs, generation of diabetic retinopathy rat model and characterization of pathological markers in ocular tissues. However, the most challenging part that I felt was the fabrication of nanoparticles and optimization of drug loading in nanoparticles so as to achieve sequential drug release.

How did the collaboration with NIN facilitate the study?
Srinivasarao:Our collaboration with NIN Hyderabad accelerated progress of the in vivo study. NIN offered state-of-the-art facilities for animal studies i.e., housing of animals, generation of diabetic retinopathy animal model, characterization of oxidative stress and neovascularization markers in lens and retinal tissues.

The Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur (IITK), invites applications for faculty positions in the areas of Regenerative Medicine, Molecular Medicine and Engineering and Digital Medicine for its newly established center, the Mehta Family Centre for Engineering in Medicine(MFCEM)

We seek highly motivated applicants at the interface of engineering and medicine, with creative ideas, bold vision, and an outstanding capacity for multi-disciplinary research. The applicants must display an ability to drive innovative research and contribute to teaching at both graduate and under graduate levels. The candidate should have a PhD or an equivalent degree in relevant disciplines and demonstrate an outstanding research track.

The institute offers a highly competitive package with intramural funding, outstanding laboratory facilities, and offers to facilitate industrial transfer of technology via Startup Incubation and Innovation Centre.

Applications can be submitted in the online portal at IITK. It should include curriculum vitae, statement of research plan, statement of teaching, contact information of referees and a cover letter. Women candidates and candidates from under-represented categories are encouraged to apply. For further enquiries, please contact the Head, Department Biological Sciences and Bioengineering ( This email address is being protected from spambots. You need JavaScript enabled to view it. ).

Areas of Specialization under the 3 Focus Areas

Regenerative Medicine:

  • Regeneration: Musculoskeletal regeneration (including bone, cartilage, ligament, tendon, muscle, etc.) with an associated need / disease context (e.g., osteoporosis, arthritis, osteosarcoma, ACL injury in sports, muscular dystrophy). Other tissues of interest include cardiac tissue, neural tissue and tumor tissue.
  • Tissue Engineering: design and development of novel 3D scaffolding systems for improved tissue regeneration. Scaffold mediated modulation of cell fate via material design strategies / growth factor or bioactive molecule delivery.  Can include manipulation of materials at smaller length scales such as the nano-/micro-meter length scale as well as strategies for immobilization and release of bioactive molecules/cytokines/chemokines.
  • Stem cell engineering: engineering and improvising stem cells for the purpose of tissue regeneration.
  • Cellular mechanosensing and mechanotransduction: This can be in specific cell types or could be with stem cells. It is desired to have it in the context of connecting physiology to pathology.
  • Immunoengineering: regenerative immunology, immunomodulatory biomaterials, immuno-onco-engineering, computational immunoengineering.
  • Sensing and diagnosis: sensing of biomolecules at all length scales (sub-cellular, cellular, tissue and organ), label free biosensors, nano-biosensors, point-of-care diagnostics, early diagnosis (i.e. ultralow analyte concentration).

Molecular Medicine and Engineering

  • Precision Medicine: Cancer, Infectious and non-communicable diseases, Predictive –Omics, Big Data and Genomic Sequencing, Targeted- and Immunotherapies, Artificial Intelligence and Machine Learning in medicine, Liquid Biopsies for diagnostics and clinical monitoring, Affordable Biomedical microfluidic devices, Multimodal Diagnostics. 
  • Genome and Cellular Engineering: Tools for Genome editing, CRISPR genome editing, Genome editing-based therapeutic solutions, Nanoscale Engineering, DNA Nanodevices for biosensing, Cellular Engineering, Cellular Microenvironment Engineering, CAR-T cell engineering, Viral and non-viral vectors for cell engineering. 
  • Drug discovery: Chemical and synthetic approaches to drug discovery, Synthetic and Medicinal Chemistry, Synthetic strategies for drug design, Nano-Drug delivery systems, Biologics Development, High-throughput drug screening, Organoid engineering for drug discovery, Vaccine development, Biosensors for drug discovery and analysis.
  • Neuroscience and Neuroengineering: Neurophysiology, Cybernetics, Brain-computer interface technologies, Sensory Information Processing, Signal processing, Computational neuroscience, in vivo imaging of neuronal network, Biosensors for neurochemical monitoring, Wearable/Implantable Sensory Systems.

Digital Medicine

  • Digital Diagnostics: Use of AI/ML for medical images, real-time monitoring of patient information using mobile sensors
  • Digital Devices: Connected implantables, point-of-care devices, closed-loop systems, monitoring of recovery, performance and treatment adherence ·
  • Digital Psychiatry: Automated software interventions for various psychiatric disorders, including depression, anxiety, and addiction. Natural language processing based conversational agents, eHealth, mHealth.
  • Digital Biology: Simulations of cells, Simulations of tissues, Systems medicine, Systems biology, Computational biology
Prof. Nitish Thakor
Johns Hopkins University
Prof. Noel Buckley
University of Oxford
Prof. Shyni Varghese
Duke University
Prof. Sriram Subramaniam
Univ. British Columbia
Prof. Victoria Seewaldt
City of Hope Cancer Center, California

The Bhupat & Jyoti Mehta Family Foundation

MFCEM at the Indian Institute of Technology Kanpur is generously supported by the Mehta Family Foundation.

Visit Website...